Ranolazine

Product NDC
71205-868
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ranolazine
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Proficient Rx LP
Application
ANDA211829
Marketing category
ANDA
Substance
RANOLAZINE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
71205-868-00100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-00) 2021-12-17NoHistorical
71205-868-3030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-30) 2021-12-17NoHistorical
71205-868-55500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-55) 2021-12-17NoHistorical
71205-868-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-60) 2021-12-17NoHistorical
71205-868-72120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-72) 2021-12-17NoHistorical
71205-868-78180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-78) 2021-12-17NoHistorical
71205-868-9090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-90) 2021-12-17NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
RanolazineProficient Rx LP2022-03-01HUMAN PRESCRIPTION DRUG LABEL2